These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15090600)

  • 1. Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton.
    Harrison RE; Sikorski BA; Jongstra J
    J Cell Sci; 2004 Apr; 117(Pt 10):2151-7. PubMed ID: 15090600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of anti-IgM-induced translocation of protein kinase C beta I inhibits ERK2 activation and increases apoptosis.
    Cao MY; Shinjo F; Heinrichs S; Soh JW; Jongstra-Bilen J; Jongstra J
    J Biol Chem; 2001 Jul; 276(27):24506-10. PubMed ID: 11333276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The actin-binding protein, lymphocyte-specific protein 1, is expressed in human leukocytes and human myeloid and lymphoid cell lines.
    Li Y; Guerrero A; Howard TH
    J Immunol; 1995 Oct; 155(7):3563-9. PubMed ID: 7561054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton.
    Martín-Encabo S; Santos E; Guerrero C
    Exp Cell Res; 2007 Nov; 313(18):3881-91. PubMed ID: 17825818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma membrane Ca(2+) -ATPase associates with CLP36, alpha-actinin and actin in human platelets.
    Bozulic LD; Malik MT; Powell DW; Nanez A; Link AJ; Ramos KS; Dean WL
    Thromb Haemost; 2007 Apr; 97(4):587-97. PubMed ID: 17393022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymphocyte-specific protein LSP1 is associated with the cytoskeleton and co-caps with membrane IgM.
    Klein DP; Galea S; Jongstra J
    J Immunol; 1990 Nov; 145(9):2967-73. PubMed ID: 2212669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNT-2 interacts with ERK2 and negatively regulates ERK2 signaling in response to EGF stimulation.
    Huang L; Gotoh N; Zhang S; Shibuya M; Yamamoto T; Tsuchida N
    Biochem Biophys Res Commun; 2004 Nov; 324(3):1011-7. PubMed ID: 15485655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK/ERK regulates adherens junctions and migration through Rac1.
    Ray RM; Vaidya RJ; Johnson LR
    Cell Motil Cytoskeleton; 2007 Mar; 64(3):143-56. PubMed ID: 17183546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton.
    Chen H; Bai J; Ye J; Liu Z; Chen R; Mao W; Li A; Zhou J
    Cell Signal; 2007 Jun; 19(6):1315-27. PubMed ID: 17336041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
    Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
    Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
    Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
    J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
    Kim M; Yan Y; Kortum RL; Stoeger SM; Sgagias MK; Lee K; Lewis RE; Cowan KH
    Cancer Res; 2005 May; 65(10):3986-92. PubMed ID: 15899786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase.
    Scuto A; Zhang H; Zhao H; Rivera M; Yeatman TJ; Jove R; Torres-Roca JF
    Cancer Res; 2007 Nov; 67(21):10317-24. PubMed ID: 17974974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte-specific gene 1 protein (LSP1) is involved in chemokine KC-activated cytoskeletal reorganization in murine neutrophils in vitro.
    Hannigan M; Zhan L; Ai Y; Huang CK
    J Leukoc Biol; 2001 Mar; 69(3):497-504. PubMed ID: 11261799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human diploid fibroblasts are resistant to MEK/ERK-mediated disruption of the actin cytoskeleton and invasiveness stimulated by Ras.
    Sukezane T; Oneyama C; Kakumoto K; Shibutani K; Hanafusa H; Akagi T
    Oncogene; 2005 Aug; 24(36):5648-55. PubMed ID: 16007212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.